A Win For GreenLight Biosciences Holdings PBC
Wed, Mar 15, 2023 at 07:06 PM
GreenLight Biosciences Holdings PBC (GRNA:NASDAQ) rocketted at $0.41, a gain of 21.5%. On Wed, Mar 15, 2023, GRNA:NASDAQ hit a New 2-Week Intraday Low of $0.32. The stock appeared on our News Catalysts scanner on Wed, Mar 01, 2023 at 06:57 AM in the 'MISCELLANEOUS' category. From Wed, Mar 01, 2023, the stock recorded 40.00% Up Days and 18.18% Green Days
About GreenLight Biosciences Holdings PBC (GRNA:NASDAQ)
GreenLight Biosciences Inc is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic acid production platform for the discovery, development, and commercialization...
Top 10 Gainers:
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 98.58%
- Elevation Oncology Inc. (ELEV:NASDAQ), 62.24%
- Loyalty Ventures Inc. (LYLT:NASDAQ), 59.35%
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 40.57%
- Mmtec, Inc. (MTC:NASDAQ), 35.75%
- Creatd Inc. (CRTD:NASDAQ), 32.74%
- Moolec Science SA (MLEC:NASDAQ), 25.16%
- Summit Healthcare Acquisition Corp. (SMIH:NASDAQ), 22.3%
- Etao International Co. Ltd. (ETAO:NASDAQ), 21.52%
- GreenLight Biosciences Holdings PBC (GRNA:NASDAQ), 21.46%